Brain Injuries

0
Pipeline Programs
4
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 5 programs with unclassified modality

Competitive Landscape

4 companies ranked by most advanced pipeline stage

B
BrainScopeMD - Bethesda
3 programs
BrainScope Ahead 200N/A1 trial
BrainScope Ahead 200N/A1 trial
BrainScope Ahead 300iP-ON/A1 trial
Active Trials
NCT02367300CompletedEst. Jan 2016
NCT02367274CompletedEst. Apr 2016
NCT04074486Completed1,318Est. Mar 2022
Abbott
AbbottABBOTT PARK, IL
1 program
Biomarker Testing using the Alinity Whole-blood TBI biomarker i-STATN/ASmall Molecule1 trial
Active Trials
NCT06932588Recruiting350Est. Jun 2026
Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal HaemorrhagesN/A1 trial
Active Trials
NCT00435006CompletedEst. Jun 2006
AB
AP BiosciencesTaiwan - Taipei
1 program
Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal HaemorrhagesN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AbbottBiomarker Testing using the Alinity Whole-blood TBI biomarker i-STAT
BrainScopeBrainScope Ahead 300iP-O
BrainScopeBrainScope Ahead 200
BrainScopeBrainScope Ahead 200
Novo NordiskHypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal Haemorrhages

Clinical Trials (5)

Total enrollment: 1,668 patients across 5 trials

NCT06932588AbbottBiomarker Testing using the Alinity Whole-blood TBI biomarker i-STAT

Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma

Start: May 2025Est. completion: Jun 2026350 patients
N/ARecruiting
NCT04074486BrainScopeBrainScope Ahead 300iP-O

Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC

Start: Oct 2019Est. completion: Mar 20221,318 patients
N/ACompleted
NCT02367300BrainScopeBrainScope Ahead 200

Validation Of TBI Detection System For Head Injured Patients

Start: Feb 2015Est. completion: Jan 2016
N/ACompleted
NCT02367274BrainScopeBrainScope Ahead 200

Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department

Start: Jan 2015Est. completion: Apr 2016
N/ACompleted
NCT00435006Novo NordiskHypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal Haemorrhages

Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal Haemorrhages

Start: Aug 2003Est. completion: Jun 2006
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 1,668 patients
4 companies competing in this space